Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-22 | New | $11,249,977 | Unknown | Equity Only | SEC link | |
| 2023-07-06 | Amended | $14,952,930 | $2,952,990 | Equity Only | 06b | SEC link |
| 2022-03-31 | New | $11,999,940 | $11,999,940 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Fredric N. Eshelman | Director, Executive |
| Patrick Roberts | Director, Executive |
| Norman Sharpless | Director |
| Sid Subramony | Director |